Jeff Shaner Sells 29,357 Shares of Aveanna Healthcare (NASDAQ:AVAH) Stock

by · The Cerbat Gem

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) CEO Jeff Shaner sold 29,357 shares of Aveanna Healthcare stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $7.85, for a total transaction of $230,452.45. Following the transaction, the chief executive officer directly owned 2,394,179 shares of the company’s stock, valued at $18,794,305.15. This represents a 1.21% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Jeff Shaner also recently made the following trade(s):

  • On Wednesday, December 31st, Jeff Shaner sold 27,674 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.18, for a total transaction of $226,373.32.
  • On Tuesday, December 30th, Jeff Shaner sold 27,929 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.36, for a total transaction of $233,486.44.

Aveanna Healthcare Price Performance

Shares of NASDAQ:AVAH traded down $0.09 during trading on Friday, reaching $8.08. The stock had a trading volume of 2,526,966 shares, compared to its average volume of 1,076,101. The stock has a market capitalization of $1.69 billion, a PE ratio of 22.44 and a beta of 2.06. The company has a debt-to-equity ratio of 140.39, a current ratio of 1.23 and a quick ratio of 1.23. Aveanna Healthcare Holdings Inc. has a 52 week low of $3.67 and a 52 week high of $10.32. The business’s 50-day moving average price is $8.92 and its 200 day moving average price is $7.49.

Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last released its quarterly earnings results on Monday, May 22nd. The company reported $0.04 EPS for the quarter. Aveanna Healthcare had a negative return on equity of 143.55% and a net margin of 3.29%.The business had revenue of $450.53 million for the quarter. As a group, equities analysts predict that Aveanna Healthcare Holdings Inc. will post -0.06 earnings per share for the current year.

Hedge Funds Weigh In On Aveanna Healthcare

A number of hedge funds and other institutional investors have recently bought and sold shares of AVAH. Banque Transatlantique SA acquired a new stake in Aveanna Healthcare during the 1st quarter worth $25,000. Quantbot Technologies LP bought a new position in shares of Aveanna Healthcare in the 2nd quarter worth $43,000. Diversified Trust Co acquired a new stake in shares of Aveanna Healthcare during the second quarter worth $57,000. Jump Financial LLC acquired a new stake in shares of Aveanna Healthcare during the first quarter worth $59,000. Finally, MQS Management LLC bought a new stake in Aveanna Healthcare in the second quarter valued at about $59,000. 87.96% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on AVAH shares. UBS Group lifted their price target on Aveanna Healthcare from $9.00 to $9.50 and gave the company a “neutral” rating in a report on Friday, November 7th. William Blair began coverage on shares of Aveanna Healthcare in a research note on Monday, December 8th. They issued an “outperform” rating for the company. JPMorgan Chase & Co. upgraded shares of Aveanna Healthcare from an “underweight” rating to a “neutral” rating and upped their target price for the stock from $6.00 to $10.00 in a research report on Thursday, September 18th. Raymond James Financial reissued an “outperform” rating and issued a $13.00 price target on shares of Aveanna Healthcare in a report on Friday, December 5th. Finally, Jefferies Financial Group boosted their price objective on shares of Aveanna Healthcare from $11.00 to $12.50 and gave the stock a “buy” rating in a research report on Tuesday, October 28th. Five investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $10.69.

Check Out Our Latest Analysis on Aveanna Healthcare

Aveanna Healthcare Company Profile

(Get Free Report)

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.

Read More